Novartis to bolster its cancer-drug portfolio with $2.9 billion deal for MorphoSys

1 year ago 4043
NEWS
  1. Homepage
  2. Finance
  3. Novartis to bolster its cancer-drug portfolio with $2.9 billion deal for MorphoSys

Related

Investors will have to wait awhile for interest-rate cuts, Fed’s Bostic says

Investors will have to wait awhile for interest-rate cuts, F...

1 year ago 4908
Oatly’s stock slides 10% after company’s loss more than doubles and it warns of another bad year

Oatly’s stock slides 10% after company’s loss more than doub...

1 year ago 4884
DoorDash’s stock drops despite reporting increase in revenue, orders

DoorDash’s stock drops despite reporting increase in revenue...

1 year ago 4896